Klaus G. Parhofer
Researcher Next ID · RN-040221
Researcher · Biochemistry, Genetics and Molecular Biology
Munich, Austria
- Works count
- 489
- Citation count
- 19,547
- H-index
- 63
- i10-index
- 180
Research interests
Publications
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
European Heart Journal · 2025 · https://doi.org/10.1093/eurheartj/ehaf190
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society
Atherosclerosis · 2023 · 10.1016/j.atherosclerosis.2023.04.012
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance
European Heart Journal · 2023 · 10.1093/eurheartj/ehad197
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement
European Heart Journal · 2022 · https://doi.org/10.1093/eurheartj/ehac361
Clinical review on triglycerides
European Heart Journal · 2019 · 10.1093/eurheartj/ehz785
Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement
The Lancet Diabetes & Endocrinology · 2019 · https://doi.org/10.1016/s2213-8587(19)30264-5
HDL cholesterol: reappraisal of its clinical relevance
Clinical Research in Cardiology · 2017 · https://doi.org/10.1007/s00392-017-1106-1
Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial
European Heart Journal · 2016 · 10.1093/eurheartj/ehw388
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
European Heart Journal · 2015 · https://doi.org/10.1093/eurheartj/ehv157
Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
Diabetes & Metabolism Journal · 2015 · 10.4093/dmj.2015.39.5.353
Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation
Journal of clinical lipidology · 2014 · 10.1016/j.jacl.2014.01.002
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
European Heart Journal · 2014 · https://doi.org/10.1093/eurheartj/ehu274
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
European Heart Journal · 2014 · https://doi.org/10.1093/eurheartj/ehu274
Diabetic dyslipidemia
Metabolism · 2014 · 10.1016/j.metabol.2014.08.010
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
The Lancet Diabetes & Endocrinology · 2013 · https://doi.org/10.1016/s2213-8587(13)70191-8
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
International Journal of Cardiology · 2013 · 10.1016/j.ijcard.2013.11.025
Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study
Clinical Endocrinology · 2012 · https://doi.org/10.1111/cen.12119
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Current Vascular Pharmacology · 2011 · 10.2174/157016111796642661
Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events
Nature Reviews Cardiology · 2009 · https://doi.org/10.1038/ncpcardio1456
Pericardial Adipose Tissue Determined by Dual Source CT Is a Risk Factor for Coronary Atherosclerosis
Arteriosclerosis Thrombosis and Vascular Biology · 2009 · https://doi.org/10.1161/atvbaha.108.180653
Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis
European Journal of Endocrinology · 2009 · https://doi.org/10.1530/eje-09-0380
Adipokines and Insulin Resistance
Molecular Medicine · 2008 · https://doi.org/10.2119/2008-00058.rabe
Liquid Chromatography Tandem-mass Spectrometry (LC-MS/MS) - Technique and Applications in Endocrinology
Experimental and Clinical Endocrinology & Diabetes · 2007 · 10.1055/s-2007-981458
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary
European Heart Journal · 2007 · 10.1093/eurheartj/ehl260
Defining high-fat-diet rat models: metabolic and molecular effects of different fat types
Journal of Molecular Endocrinology · 2006 · 10.1677/jme.1.01909
Current projects
No projects listed.